Dysfunction of glutamate receptors in microglia may cause neurodegeneration

Current Alzheimer Research

Volumn 13, Issue 4, 2016, Pages 381-386

  Noda, Mami ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

AMPA receptor; Ca2+ permeability; GluA2; Microglia; Neurodegeneration; TNF

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM ION; CYTOKINE; GLUTAMATE RECEPTOR; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; CALCIUM;

ALZHEIMER DISEASE; ARTICLE; CELL ACTIVATION; CELL DISRUPTION; CELL MEMBRANE; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; HUMAN; MICROGLIA; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURFACE PROPERTY; SYNAPTIC TRANSMISSION; ANIMAL; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CALCIUM; CYTOKINES; HUMANS; MICROGLIA; NERVE DEGENERATION; RECEPTORS, GLUTAMATE; SYNAPTIC TRANSMISSION;

EID: 84964077901     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205013666151116125810     Document Type: Article

References (60)

1. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. Physiology of microglia. Physiol Rev 91: 461-553 (2011).
2. Noda M, Verkhratsky A. Phyiology of microglia. In: Kettenmann H, Ransom BR, Eds. Neuroglia 3rd ed. Oxford: Oxford University Press pp. 223-37 (2013).
3. Noda M, Nakanishi H, Nabekura J, Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J Neurosci 20: 251-8 (2000).
4. Hagino Y, Kariura Y, Manago Y, Amano T, Wang B, Sekiguchi M, et al. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. Glia 47: 68-77 (2004).
5. Kaindl AM, Degos V, Peineau S, Gouadon E, Chhor V, Loron G, et al. Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 72: 536-49 (2012).
6. Biber K, Laurie DJ, Berthele A, Sommer B, Tolle TR, Gebicke-Harter PJ, et al. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J Neurochem 72: 1671-80 (1999).
7. Taylor DL, Diemel LT, Cuzner ML, Pocock JM. Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer’s disease. J Neurochem 82: 1179-91 (2002).
8. Taylor DL, Diemel LT, Pocock JM. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J Neurosci 23: 2150-60 (2003).
9. Lopez-Redondo F, Nakajima K, Honda S, Kohsaka S. Glutamate transporter GLT-1 is highly expressed in activated microglia following facial nerve axotomy. Brain Res Mol Brain Res 76: 429-35 (2000).
10. Nakajima K, Yamamoto S, Kohsaka S, Kurihara T. Neuronal stimulation leading to upregulation of glutamate transporter-1 (GLT-1) in rat microglia in vitro. Neurosci Lett 436: 331-4 (2008).
11. Bezzi P, Domercq M, Brambilla L, Galli R, Schols D, De Clercq E, et al. CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4: 702-10 (2001).
12. Ferrer I, Puig B. GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease. Acta Neuropathol 106: 311-8 (2003).
13. Carter TL, Rissman RA, Mishizen-Eberz AJ, Wolfe BB, Hamilton RL, Gandy S, et al. Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer’s disease patients according to Braak stage. Exp Neurol 187: 299-309 (2004).
14. Gallo V, Ghiani CA. Glutamate receptors in glia: new cells, new inputs and new functions. Trends Pharmacol Sci 21: 252-8 (2000).
15. Moriguchi S, Mizoguchi Y, Tomimatsu Y, Hayashi Y, Kadowaki T, Kagamiishi Y, et al. Potentiation of NMDA receptor-mediated synaptic responses by microglia. Brain Res Mol Brain Res 119: 160-9 (2003).
16. Hayashi Y, Ishibashi H, Hashimoto K, Nakanishi H. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia 53: 660-8 (2006).
17. Nakajima K, Tohyama Y, Maeda S, Kohsaka S, Kurihara T. Neuronal regulation by which microglia enhance the production of neurotrophic factors for GABAergic, catecholaminergic, and cholinergic neurons. Neurochem Int 50: 807-20 (2007).
18. Moran LB, Graeber MB. The facial nerve axotomy model. Brain Res Brain Res Rev 44: 154-78 (2004).
19. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-94 (2007).
20. Blinzinger K, Kreutzberg G. Displacement of synaptic terminals from regenerating motoneurons by microglial cells. Z Zellforsch Mikrosk Anat 85: 145-57 (1968).
21. Tremblay ME, Lowery RL, Majewska AK. Microglial interactions with synapses are modulated by visual experience. PLoS Biol 8: e1000527 (2010).
22. Miyamoto A, Wake H, Moorhouse AJ, Nabekura J. Microglia and synapse interactions: fine tuning neural circuits and candidate molecules. Front Cell Neurosci 7: 70 (2013).
23. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333: 1456-8 (2011).
24. Biber K, Neumann H, Inoue K, Boddeke HW. Neuronal ’On’ and ’Off’ signals control microglia. Trends Neurosci 30: 596-602 (2007).
25. Marin-Teva JL, Dusart I, Colin C, Gervais A, Van Rooijen N, Mallat M. Microglia promote the death of developing Purkinje cells. Neuron 41: 535-47 (2004).
26. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell 131: 1164-78 (2007).
27. Stephan AH, Barres BA, Stevens B. The complement system: an unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci 35: 369-89 (2012).
28. Bialas AR, Stevens B. Glia: regulating synaptogenesis from multiple directions. Curr Biol 22: R833-5 (2012).
29. Verkhratsky A, Noda M. General Physiology and Pathophysiology of Microglia. In: Peterson PK, Toborek M, Eds. Neuroinflammation and Neurodegeneration. New York: Springer Science+Business Media pp. 47-60 (2014).
30. Ong WY, Levine JM. A light and electron microscopic study of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte precursor cells in the normal and kainate-lesioned rat hippocampus. Neuroscience 92: 83-95 (1999).
31. Verkhratsky A, Butt AM. Microglia. In: Verkhratsky A, Butt AM, Eds. Glial Physiology and Pathophysiology. 1st ed: USA: Wiley-Blackwell pp. 347-80 (2013).
32. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29: 3974-80 (2009).
33. Kettenmann H, Kirchhoff F, Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron 77: 10-8 (2013).
34. Wake H, Moorhouse AJ, Miyamoto A, Nabekura J. Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci 36: 209-17 (2013).
35. Yamada J, Sawada M, Nakanishi H. Cell cycle-dependent regulation of kainate-induced inward currents in microglia. Biochem Biophys Res Commun 349: 913-9 (2006).
36. Sivakumar V, Ling EA, Lu J, Kaur C. Role of glutamate and its receptors and insulin-like growth factors in hypoxia induced periventricular white matter injury. Glia 58: 507-23 (2010).
37. Liu GJ, Kalous A, Werry EL, Bennett MR. Purine release from spinal cord microglia after elevation of calcium by glutamate. Mol Pharmacol 70: 851-859 (2006).
38. Eun SY, Hong YH, Kim EH, Jeon H, Suh YH, Lee JE, et al. Glutamate receptor-mediated regulation of c-fos expression in cultured microglia. Biochem Biophys Res Commun 325: 320-7 (2004).
39. Taylor DL, Jones F, Kubota ES, Pocock JM. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. J Neurosci 25: 2952-64 (2005).
40. Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem Int 51: 333-55 (2007).
41. Xin WJ, Weng HR, Dougherty PM. Plasticity in expression of the glutamate transporters GLT-1 and GLAST in spinal dorsal horn glial cells following partial sciatic nerve ligation. Mol Pain 5: 15 (2009).
42. Gras G, Samah B, Hubert A, Leone C, Porcheray F, Rimaniol AC. EAAT expression by macrophages and microglia: still more questions than answers. Amino Acids 42: 221-9 (2012).
43. Takaki J, Fujimori K, Miura M, Suzuki T, Sekino Y, Sato K. Lglutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflamm: the ’collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammation. J Neuroinflamm 9: 275 (2012).
44. Noda M, Nakanishi H, Akaike N. Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide. Neuroscience 92: 1465-74 (1999).
45. Nakajima K, Tohyama Y, Kohsaka S, Kurihara T. Ability of rat microglia to uptake extracellular glutamate. Neurosci Lett 307: 171-4 (2001).
46. Collingridge GL, Olsen RW, Peters J, Spedding M. A nomenclature for ligand-gated ion channels. Neuropharmacology 56: 2-5 (2009).
47. Wu TY, Liu CI, Chang YC. A study of the oligomeric state of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring glutamate receptors in the synaptic junctions of porcine brain. Biochem J 319(Pt 3): 731-9 (1996).
48. Rosenmund C, Stern-Bach Y, Stevens CF. The tetrameric structure of a glutamate receptor channel. Science 280: 1596-9 (1998).
49. 2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15: 193-204 (1995).
50. Liu SQ, Cull-Candy SG. Synaptic activity at calcium-permeable AMPA receptors induces a switch in receptor subtype. Nature 405: 454-8 (2000).
51. Beppu K, Kosai Y, Kido MA, Akimoto N, Mori Y, Kojima Y, et al. Expression, subunit composition, and function of AMPA-type glutamate receptors are changed in activated microglia; possible contribution of GluA2 (GluR-B)-deficiency under pathological conditions. Glia 61: 881-91 (2013).
52. Shepherd JD, Huganir RL. The cell biology of synaptic plasticity: AMPA receptor trafficking. Annu Rev Cell Dev Biol 23: 613-643 (2007).
53. Bassani S, Valnegri P, Beretta F, Passafaro M. The GLUR2 subunit of AMPA receptors: synaptic role. Neuroscience 158: 55-61 (2009).
54. Jiang J, Suppiramaniam V, Wooten MW. Posttranslational modifications and receptor-associated proteins in AMPA receptor trafficking and synaptic plasticity. Neurosignals 15: 266-82 (2006).
55. Newcombe J, Uddin A, Dove R, Patel B, Turski L, Nishizawa Y, et al. Glutamate receptor expression in multiple sclerosis lesions. Brain Pathol 18: 52-61 (2008).
56. Noda M, Beppu K. Contribution of microglial glutamate receptors to inflammatory response upon neurodegenerative diseases. J Neurol Disord 1: 131 (2013).
57. Noda M. Possible therapeutic targets in microglia. In: Parpurr V, Verkhratsky A, Eds. Pathological Potential of Neuroglia: Possible New Targets for Medical Intervention. Boston, MA: Springer pp. 293-313 (2014).
58. Dantzer R, Wollman E. Molecular mechanisms of fever: the missing links. Eur Cytokine Netw 9: 27-31 (1998).
59. Maier SF, Wiertelak EP, Martin D, Watkins LR. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res 623: 321-4 (1993).
60. Walter S, Letiembre M, Liu Y, Heine H, Penke B, Hao W, et al Role of the toll-like receptor 4 in neuroinflammation in Alzheimer’s disease. Cell Physiol Biochem 20: 947-56 (2007).